102 related articles for article (PubMed ID: 17142577)
1. Adenoid cystic/basal cell carcinoma of the prostate strongly expresses HER-2/neu.
Iczkowski KA; Montironi R
J Clin Pathol; 2006 Dec; 59(12):1327-30. PubMed ID: 17142577
[TBL] [Abstract][Full Text] [Related]
2. Adenoid cystic/basal cell carcinoma of the prostate: clinicopathologic findings in 19 cases.
Iczkowski KA; Ferguson KL; Grier DD; Hossain D; Banerjee SS; McNeal JE; Bostwick DG
Am J Surg Pathol; 2003 Dec; 27(12):1523-9. PubMed ID: 14657711
[TBL] [Abstract][Full Text] [Related]
3. Adenoid cystic carcinomas of the breast have low Topo IIα expression but frequently overexpress EGFR protein without EGFR gene amplification.
Vranic S; Frkovic-Grazio S; Lamovec J; Serdarevic F; Gurjeva O; Palazzo J; Bilalovic N; Lee LM; Gatalica Z
Hum Pathol; 2010 Nov; 41(11):1617-23. PubMed ID: 20688355
[TBL] [Abstract][Full Text] [Related]
4. Basal cell proliferations of the prostate other than usual basal cell hyperplasia: a clinicopathologic study of 23 cases, including four carcinomas, with a proposed classification.
McKenney JK; Amin MB; Srigley JR; Jimenez RE; Ro JY; Grignon DJ; Young RH
Am J Surg Pathol; 2004 Oct; 28(10):1289-98. PubMed ID: 15371944
[TBL] [Abstract][Full Text] [Related]
5. Dedifferentiated adenoid cystic carcinoma: a clinicopathologic study of 6 cases.
Nagao T; Gaffey TA; Serizawa H; Sugano I; Ishida Y; Yamazaki K; Tokashiki R; Yoshida T; Minato H; Kay PA; Lewis JE
Mod Pathol; 2003 Dec; 16(12):1265-72. PubMed ID: 14681328
[TBL] [Abstract][Full Text] [Related]
6. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of HER-2/neu expression in prostatic adenocarcinoma: a requested for a standardized, organ specific methodology.
Sanchez KM; Sweeney CJ; Mass R; Koch MO; Eckert GJ; Geary WA; Baldridge LA; Zhang S; Eble JN; Cheng L
Cancer; 2002 Oct; 95(8):1650-5. PubMed ID: 12365012
[TBL] [Abstract][Full Text] [Related]
8. Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial.
Lara PN; Chee KG; Longmate J; Ruel C; Meyers FJ; Gray CR; Edwards RG; Gumerlock PH; Twardowski P; Doroshow JH; Gandara DR
Cancer; 2004 May; 100(10):2125-31. PubMed ID: 15139054
[TBL] [Abstract][Full Text] [Related]
9. Basaloid carcinoma of the prostate: an extremely rare tumor.
Rodriguez-Carlin A; Arellano L; López-Fontana G; Bolufer E; Castillo OA
Arch Esp Urol; 2013 May; 66(4):380-4. PubMed ID: 23676544
[TBL] [Abstract][Full Text] [Related]
10. Adenoid cystic/basal cell carcinoma of the prostate: review and update.
Begnami MD; Quezado M; Pinto P; Linehan WM; Merino M
Arch Pathol Lab Med; 2007 Apr; 131(4):637-40. PubMed ID: 17425398
[TBL] [Abstract][Full Text] [Related]
11. Basal cell carcinoma of the prostate: a clinicopathologic study of 29 cases.
Ali TZ; Epstein JI
Am J Surg Pathol; 2007 May; 31(5):697-705. PubMed ID: 17460452
[TBL] [Abstract][Full Text] [Related]
12. Adenoid cystic/basal cell carcinoma of the prostate.
Halat SK; MacLennan GT
J Urol; 2008 Apr; 179(4):1576. PubMed ID: 18295260
[No Abstract] [Full Text] [Related]
13. Basal cell hyperplasia, adenoid basal cell tumor, and adenoid cystic carcinoma of the prostate gland: an immunohistochemical study.
Grignon DJ; Ro JY; Ordoñez NG; Ayala AG; Cleary KR
Hum Pathol; 1988 Dec; 19(12):1425-33. PubMed ID: 2461340
[TBL] [Abstract][Full Text] [Related]
14. Basal cell carcinoma of the prostate: current concepts.
Ayyathurai R; Civantos F; Soloway MS; Manoharan M
BJU Int; 2007 Jun; 99(6):1345-9. PubMed ID: 17419700
[No Abstract] [Full Text] [Related]
15. A subset of prostatic basal cell carcinomas harbor the MYB rearrangement of adenoid cystic carcinoma.
Bishop JA; Yonescu R; Epstein JI; Westra WH
Hum Pathol; 2015 Aug; 46(8):1204-8. PubMed ID: 26089205
[TBL] [Abstract][Full Text] [Related]
16. Adenoid cystic and adenoid basal carcinomas of the cervix.
van Dinh T; Woodruff JD
Obstet Gynecol; 1985 May; 65(5):705-9. PubMed ID: 2580256
[TBL] [Abstract][Full Text] [Related]
17. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
Lyne JC; Melhem MF; Finley GG; Wen D; Liu N; Deng DH; Salup R
Cancer J Sci Am; 1997; 3(1):21-30. PubMed ID: 9072304
[TBL] [Abstract][Full Text] [Related]
18. Expression of c-erbB family gene products in adenoid cystic carcinoma of salivary glands: an immunohistochemical study.
Shintani S; Funayama T; Yoshihama Y; Alcalde RE; Ootsuki K; Terakado N; Matsumura T
Anticancer Res; 1995; 15(6B):2623-6. PubMed ID: 8669836
[TBL] [Abstract][Full Text] [Related]
19. [Expression of C-erbB-2 oncogene mRNA in salivary gland tumors].
Sun H; Wu S; Ouyang J
Zhonghua Kou Qiang Yi Xue Za Zhi; 1999 Sep; 34(5):289-91. PubMed ID: 11776895
[TBL] [Abstract][Full Text] [Related]
20. Adenoid basal hyperplasia of the uterine cervix: a lesion of reserve cell type, distinct from adenoid basal carcinoma.
Kerdraon O; Cornélius A; Farine MO; Boulanger L; Wacrenier A
Hum Pathol; 2012 Dec; 43(12):2255-65. PubMed ID: 22809729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
